Michael Mulkerrin, PhD, is Vice President, Head of CMC at ADC Therapeutics.
Dr. Mulkerrin has extensive experience in biologics manufacturing. Prior to joining ADC Therapeutics, he was Vice President, Process Development and Manufacturing at OncoMed Pharmaceuticals.
Prior to OncoMed, Dr. Mulkerrin was the Senior Director in Process Sciences at Amgen, where he led Analytical Biochemistry. He also served in leadership positions in the development of therapeutic monoclonal antibody projects at Genentech and Abgenix. In 2010, Dr. Mulkerrin was elected to the USP Council of Experts and is Chairman of the Biologics Monographs – Proteins Expert Committee.
Dr. Mulkerrin has a B.S. in Biochemistry from the University of Massachusetts, Amherst, and a PhD in Biochemistry from the University of Georgia, Athens.